Advertisement

Neonatology pp 993-1003 | Cite as

Disorders of Thyroid Function

  • Paolo Cavarzere
  • Luciano Tatò

Abstract

The thyroid is a bilobed gland located in the neck region, made up of two types of cells: the follicular cells which produce thyroxine and the parafollicular cells which produce calcitonin. The follicular cells are the predominant cell population in the gland and they derive from the endoderm, whereas parafollicular cells are of neuroectodermal origin [1]. These different types of cells migrate from their respective sites of origin to ultimately merge in the definitive thyroid gland. The follicular cells organize into thyroid follicles whereas the other type of cells scatters into the interfollicular space [2]. Most thyroid function disorders are related to developmental or enzymatic defects involved in the process of thyroid hormone production.

Keywords

Thyroid Hormone Thyroid Stimulate Hormone Congenital Hypothyroidism Thyroid Stimulate Hormone Level Thyroid Follicular Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hoyes AD, Kershaw DR (1985) Anatomy and development of the thyroid gland. Ear Nose Throat J 64: 318–333PubMedGoogle Scholar
  2. 2.
    De Felice M, Di Lauro R (2004) Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25: 722–746PubMedCrossRefGoogle Scholar
  3. 3.
    O’Rahilly R (1983) The timing and sequence of events in the development of the human endocrine system during the embryonic period proper. Anat Embryol 166: 439–451PubMedCrossRefGoogle Scholar
  4. 4.
    Sgalitzer KE (1941) Contribution to the study of the morphogenesis of the thyroid gland. J Anat 75: 389–405PubMedGoogle Scholar
  5. 5.
    Ellis PD, van Nostrand AW (1977) The applied anatomy of thyroglossal tract remnants Laryngoscope 87: 765–770Google Scholar
  6. 6.
    Fisher DA, Dussault JH, Sack J, Chopra J (1977) Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep and rat. Recent Prog Horm Res 33: 59–116Google Scholar
  7. 7.
    Macchia PE, De Felice M, Di Lauro R (1999) Molecular genetics of congenital hypothyroidism. Curr Opin Genet Dev 9: 289–294PubMedCrossRefGoogle Scholar
  8. 8.
    Park SM, Chatterjee VK (2005) Genetics of congenital hypothyroidism. J Med Genet 42: 379–389PubMedCrossRefGoogle Scholar
  9. 9.
    Kopp P (2002) Perspective: genetic defects in the etiology of congenital hypothyroidism. Endocrinology 143: 2019–2024PubMedCrossRefGoogle Scholar
  10. 10.
    Polak M, Sura-Trueba S, Chauty A et al (2004) Molecular mechanisms of thyroid dysgenesis. Horm Res 62 (Supp 13): 14–21PubMedCrossRefGoogle Scholar
  11. 11.
    Griiters A, Biebermann H, Krude H (2003) Neonatal thyroid disorders. Horm Res 59 (Suppl 1): 24–29CrossRefGoogle Scholar
  12. 12.
    De Felice M, Di Lauro R (2007) Murine models for the study of thyroid gland development. Endocr Dev 10: 1–14PubMedCrossRefGoogle Scholar
  13. 13.
    Vulsma T, Gons MH, de Vijlder JJ (1989) Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 321: 13–16PubMedCrossRefGoogle Scholar
  14. 14.
    Richard K, Hume R, Kaptein E et al (1998) Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab 83: 2868–2874PubMedCrossRefGoogle Scholar
  15. 15.
    Santini F, Chiovato L, Ghirri P et al (1999) Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. J Clin Endocrinol Metab 84: 493–498PubMedCrossRefGoogle Scholar
  16. 16.
    Kester MH, Martinez de Mena R, Obregon MJ et al (2004) Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 89: 3117–3128PubMedCrossRefGoogle Scholar
  17. 17.
    Fisher DA (1998) Thyroid function in premature infants. The hypothyroxinemia of prematurity. Clin Perinatol 25: 999–1014PubMedGoogle Scholar
  18. 18.
    LaFranchi S (1999) Thyroid function in the preterm infant. Thyroid 9: 71–78PubMedCrossRefGoogle Scholar
  19. 19.
    van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ (1997) Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 42: 604–609PubMedCrossRefGoogle Scholar
  20. 20.
    John R, Bamforth FJ (1987) Serum free thyroxine and free triiodothyronine concentrations in healthy fullterm, preterm and sick preterm neonates. Ann Clin Biochem 24: 461–465PubMedGoogle Scholar
  21. 21.
    Haddow JE, Palomaki GE, Allan WC et al (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341: 549–555PubMedCrossRefGoogle Scholar
  22. 22.
    de Escobar GM, Obregón MJ, del Rey FE (2004) Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 18: 225–248PubMedCrossRefGoogle Scholar
  23. 23.
    Glinoer D (2001) Potential consequences of maternal hypothyroidism on the offspring: evidence and implications. Horm Res 55: 109–114PubMedCrossRefGoogle Scholar
  24. 24.
    Morreale de Escobar G, Obregón MJ, Escobar del Rey F (2000) Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85: 3975–3987PubMedCrossRefGoogle Scholar
  25. 25.
    Rapaport R, Rose SR, Freemark M (2001) Hypothyroxinemia in the preterm infanta the benefits and risks of thyroxine treatment. J Pediatr 139: 182–188PubMedCrossRefGoogle Scholar
  26. 26.
    Van Vliet G (2004) Hypothyroidism in infants and children: congenital hypothyroidism. In: The thyroid: a fundamental and clinical text. Braveman LE, Utiger RD (eds) Lippincott Williams & Wilkins, New YorkGoogle Scholar
  27. 27.
    van Trotsenburg AS, Vulsma T, van Santen HM et al (2003) Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 88: 1512–1515PubMedCrossRefGoogle Scholar
  28. 28.
    Fisher DA, Klein AH (1981) Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 304: 702–712PubMedCrossRefGoogle Scholar
  29. 29.
    Grüters A, Finke R, Krude H, Meinhold H (1994) Etiological grouping of congenital hypothyroidism with a thyroid gland in situ. Horm Res 41: 3–9PubMedGoogle Scholar
  30. 30.
    Devriendt K, Vanhole C, Matthijs G, de Zegher F (1998) Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 338: 1317–1318PubMedCrossRefGoogle Scholar
  31. 31.
    Krude H, Schütz B, Biebermann H et al (2002) Choreoathetosis, hypothyroidism and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 109: 475–480PubMedGoogle Scholar
  32. 32.
    Bamforth JS, Hughes IA, Lazarus JH et al (1989) Congenital hypothyroidism, spiky hair, and cleft palate. J Med Genet 26: 49–51PubMedCrossRefGoogle Scholar
  33. 33.
    Macchia PE, Lapi P, Krude H et al (1998) PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 19: 83–86PubMedCrossRefGoogle Scholar
  34. 34.
    Congdon T, Nguyen LQ, Nogueira CR et al (2001) A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child. J Clin Endocrinol Metab 86: 3962–3967PubMedCrossRefGoogle Scholar
  35. 35.
    Meeus L, Gilbert B, Rydlewski C et al (2004) Characterization of a novel loss of function mutation of PAX8 in a familial case of congenital hypothyroidism with in-piace, normalsized thyroid. J Clin Endocrinol Metab 89: 4285–4291PubMedCrossRefGoogle Scholar
  36. 36.
    Caputo M, Rivolta CM, Gutnisky VJ et al (2007) Recurrence of the p.R277X/p.R1511X compound heterozygous mutation in the thyroglobulin gene in unrelated families with congenital goiter and hypothyroidism: haplotype analysis using intragenic thyroglobulin polymorphisms. J Endocrinol 195: 167–177PubMedCrossRefGoogle Scholar
  37. 37.
    Fujiwara H, Tatsumi K, Miki K et al (1997) Congenital hypothyroidism caused by a mutation in the Na+/I– symporter. Nat Genet 16: 124–125PubMedCrossRefGoogle Scholar
  38. 38.
    Szinnai G, Kosugi S, Derrien C et al (2006) Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype- phenotype correlations in ITD. J Clin Endocrinol Metab 91: 1199–1204PubMedCrossRefGoogle Scholar
  39. 39.
    Everett LA, Glaser B, Beck JC et al (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411–422PubMedCrossRefGoogle Scholar
  40. 40.
    Palos F, García-Rendueles ME, Araujo-Vilar D et al (2008) Pendred syndrome in two Galiacian families: insights into clinical phenotypes through cellular, genetic, and molecular studies. J Clin Endocrinol Metab 93: 267–277PubMedCrossRefGoogle Scholar
  41. 41.
    Abramowicz MJ, Targovnik HM, Varela V et al (1992) Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 90: 1200–1204PubMedCrossRefGoogle Scholar
  42. 42.
    Bakker B, Bikker H, Vulsma T et al (2000) Two decades of screening for congenita hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab 85: 3708–3712PubMedCrossRefGoogle Scholar
  43. 43.
    Tenenbaum-Rakover Y, Mamanasiri S, Risstalpers C et al (2007) Clinical and genetic characteristics of congenital hypothyroidism due to mutations in the thyroid peroxidase (TPO) gene in Israelis. Clin Endocrinol 66: 695–702CrossRefGoogle Scholar
  44. 44.
    Moreno JC, Bikker H, Kempers MI et al (2002) Inactivating mutations in the gene for thyroid oxidaxe 2 (DUOX2) and congenital hypothyroidism. N Engl J Med 347: 95–102PubMedCrossRefGoogle Scholar
  45. 45.
    Moreno JC, Visser TJ (2007) New phenotypes in thyroid dyshormonogenesis: hypothyroidism due to DUOX2 mutations. Endocr Dev 10: 99–117PubMedCrossRefGoogle Scholar
  46. 46.
    Zamproni I, Grasberger H, Cortinovis F et al (2008) Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 93: 605–610PubMedCrossRefGoogle Scholar
  47. 47.
    Castanet M, Polak M, Bonaiti-Pellié C et al (2001) Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 86: 2009–2014PubMedCrossRefGoogle Scholar
  48. 48.
    Abramowicz MJ, Duprez L, Parma J et al (1997) Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 99: 3018–3024PubMedCrossRefGoogle Scholar
  49. 49.
    Weinstein LS, Yu S, Warner DR, Liu J (2001) Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 22: 675–705PubMedCrossRefGoogle Scholar
  50. 50.
    Xie J, Pannain S, Pohlenz J et al (1997) Resistance to thyrotropin ( TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab 82: 3933–3939PubMedCrossRefGoogle Scholar
  51. 51.
    Grüters A, Krude H, Biebermann H (2004) Molecular genetic defects in congenital hypothyroidism. Eur J Endocrino1 151 (Supp13): U39–U44CrossRefGoogle Scholar
  52. 52.
    Niimi H, Inomata H, Sasaki N, Nakajima H (1982) Congenital isolated thyrotrophin releasing hormone deficiency. Arch Dis Child 57: 877–878PubMedCrossRefGoogle Scholar
  53. 53.
    Pohlenz J, Dumitrescu A, Aumann U et al (2002) Congenital secondary hypothyroidism caused by exon skipping due to a homozygous donor splice site mutation in the TSHbeta-subunit gene. J Clin Endocrinol Metab 87: 336–339PubMedCrossRefGoogle Scholar
  54. 54.
    Kempers MJ, van Tijn DA, van Trotsenburg AS et al (2003) Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 88: 5851–5857PubMedCrossRefGoogle Scholar
  55. 55.
    Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14: 348–399PubMedGoogle Scholar
  56. 56.
    Friesema EC, Grueters A, Biebermann H et al (2004) Association between mutations in a thyroid hormone transporter and severe Xlinked psychomotor retardation. Lancet 364: 1435–1437PubMedCrossRefGoogle Scholar
  57. 57.
    Chanoine JP, Pardou A, Bourdoux P, Delange F (1988) Withdrawal of iodinated disinfectants at delivery decreases the recall rate at neonatal screening for congenital hypothyroidism. Arch Dis Child 63: 1297–1298PubMedCrossRefGoogle Scholar
  58. 58.
    Matsuura N, Yamada Y, Nohara Y et al (1980) Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med 303: 738–741PubMedCrossRefGoogle Scholar
  59. 59.
    LaFranchi SH, Austin J (2007) How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab 20: 559–578PubMedCrossRefGoogle Scholar
  60. 60.
    Carranza D, Van Vliet G, Polak M (2006) Congenital hypothyroidism. Ann Endocrinol (Paris) 67: 295–302CrossRefGoogle Scholar
  61. 61.
    Van Vliet G, Larroque B, Bubuteishvili L et al (2003) Association of Frangaise pour le Dépistage et la Prévention des Handicaps de l’Enfant: Sex-specific impact of congenital hypothyroidism due to thyroid dysgenesis on skeletal maturation in term newborns. J Clin Endocrinol Metab 88: 2009–2013PubMedCrossRefGoogle Scholar
  62. 62.
    Olivieri A, Stazi MA, Mastroiacovo P et al (2002) A populationbased study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991-1998). J Clin Endocrinol Metab 87: 557–562PubMedCrossRefGoogle Scholar
  63. 63.
    Van Vliet G, Czernichow P (2004) Screening for neonatal endocrinopathies: rationale, methods and results. Semin Neonatol 9: 75–85PubMedCrossRefGoogle Scholar
  64. 64.
    American Academy of Pediatrics, Rose SR; Section on Endocrinology and Committee on Genetics et al (2006) Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 117: 2290–2303PubMedCrossRefGoogle Scholar
  65. 65.
    Fisher DA (1987) Effectiveness of newborn screening programs for congenital hypothyroidism: prevalence of missed cases. Pediatr Clin North Am 34: 881–890PubMedGoogle Scholar
  66. 66.
    Grüters A, Krude H (2007) Update on the management of congenital hypothyroidism. Horm Res 68 (Suppl 5): 107–111PubMedCrossRefGoogle Scholar
  67. 67.
    Daneman D, Daneman A (2005) Diagnostic imaging of the thyroid and adrenal glands in childhood. Endocrinol Metab Clin North Am 34: 745–768PubMedCrossRefGoogle Scholar
  68. 68.
    Delange F, Bürgi H, Chen ZP, Dunn JT (2002) World status of monitoring iodine deficiency disorders control programs. Thyroid 12: 915–924PubMedCrossRefGoogle Scholar
  69. 69.
    Etling N, Padovani E, Gehin-Fouque F, Tato L (1984) Serum and urine thyroid hormone levels in healthy preterm and small for date infants on the first and fifth day of life. Hely Paediatr Acta 39: 223–230Google Scholar
  70. 70.
    Schoen EJ, Clapp W, To TT, Fireman BH (2004) The key role of newborn thyroid scintigraphy with isotopic iodide (1231) in defining and managing congenital hypothyroidism. Pediatrics 114: e683–e688PubMedCrossRefGoogle Scholar
  71. 71.
    Djemli A, Fillion M, Belgoudi J et al (2004) Twenty years later: a reevaluation of the contribution of plasma thyroglobulin to the diagnosis of thyroid dysgenesis in infants with congenital hypothyroidism. Clin Biochem 37: 818–822PubMedCrossRefGoogle Scholar
  72. 72.
    Meller J, Zappel H, Conrad M et al (1997) Diagnostic value of 123- iodine scintigraphy and perchlorate discharge test in the diagnosis of congenital hypothyroidism. Exp Clin Endocrinol Diabetes 105 (Suppl 4): 24–27PubMedCrossRefGoogle Scholar
  73. 73.
    Bubuteishvili L, Garel C, Czernichow P, Léger J (2003) Thyroid abnormalities by ultrasonography in neonates with congenital hypothyroidism. J Pediatr 143: 759–764PubMedCrossRefGoogle Scholar
  74. 74.
    Ranzini AC, Ananth CV, Smulian JC et al (2001) Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. J Ultrasound Med 20: 613–617PubMedGoogle Scholar
  75. 75.
    Perry RJ, Maroo S, Maclennan AC et al (2006) Combined ultrasound and isotope scanning is more informative in the diagnosis of congenital hypothyroidism than single scanning. Arch Dis Child 91: 972–976PubMedCrossRefGoogle Scholar
  76. 76.
    Delange F, Heidemann P, Bourdoux P et al (1986) Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biol Neonate 49: 322–330PubMedCrossRefGoogle Scholar
  77. 77.
    Mengreli C, Maniati-Christidi M, Kanaka-Gantenbein C et al (2003) Transient congenital hypothyroidism due to maternal autoimmune thyroid disease. Hormones 2: 113–119PubMedGoogle Scholar
  78. 78.
    Chiovato L, Lapi P, Santini F et al (1994) Thyroid autoimmunity and congenital hypothyroidism. Ann Ist Super Sanità 30: 317–323PubMedGoogle Scholar
  79. 79.
    Wasniewska M, De Luca F, Cassio A et al (2003) In congenital hypothyroidism bone maturation at birth may be a predictive factor of psychomotor development during the first year of life irrespective of other variables related to treatment. Eur J Endocrinol 149: 1–6PubMedCrossRefGoogle Scholar
  80. 80.
    Bongers-Schokking JJ, Koot HM, Wiersma D et al (2000) Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 136: 292–297PubMedCrossRefGoogle Scholar
  81. 81.
    Hanukoglu A, Perlman K, Shamis I et al (2001) Relationship of etiology to treatment in congenital hypothyroidism. J Clin Endocrinol Metab 86: 186–191PubMedCrossRefGoogle Scholar
  82. 82.
    Cassio A, Cacciari E, Cicognani A et al (2003) Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine? Pediatrics 111: 1055–1060PubMedCrossRefGoogle Scholar
  83. 83.
    Eugster EA, LeMay D, Zerin JM, Pescovitz OH (2004) Definitive diagnosis in children with congenital hypothyroidism. J Pediatr 144: 643–647PubMedCrossRefGoogle Scholar
  84. 84.
    Baloch Z, Carayon P, Conte-Devolx B et al (2003) Guidelines Committee, National Academy of Clinical Biochemistry. Labora- tory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13: 3–126PubMedCrossRefGoogle Scholar
  85. 85.
    Simoneau-Roy J, Marti S, Deal C et al (2004) Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 144: 747–752PubMedGoogle Scholar
  86. 86.
    Rovet JF (2002) Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Child Neuropsychol 8: 150–162PubMedCrossRefGoogle Scholar
  87. 87.
    Van Vliet G (2001) Treatment of congenital hypothyroidism. Lancet 358: 86–87PubMedCrossRefGoogle Scholar
  88. 88.
    Léger J, Larroque B, Norton J; Association Française pour le Dépistage et la Prévetion des Handicaps de l’Enfant. (2001) Influence of severity of congenital hypothyroidism and adequacy of treatment on school achievement in young adolescents: a population- based cohort study. Acta Paediatr 90: 1249–1256Google Scholar
  89. 89.
    Rochiccioli P, Rogé B, Alexandre F, Tauber MT (1992) School achievement in children with hypothyroidism detected at birth and search for predictive factors. Horm Res 38: 236–240PubMedCrossRefGoogle Scholar
  90. 90.
    Ogilvy-Stuart AL (2002) Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed 87: 165–171CrossRefGoogle Scholar
  91. 91.
    Murphy N, Hume R, van Toor H et al (2004) The hypothalamicpituitary- thyroid axis in preterm infants; changes in the first 24 hours of postnatal life. J Clin Endocrinol Metab 89: 2824–2831PubMedCrossRefGoogle Scholar
  92. 92.
    Williams FL, Visser TJ, Hume R (2006) Transient hypothyroxinaemia in preterm infants. Early Hum Dev 82: 797–802PubMedCrossRefGoogle Scholar
  93. 93.
    De Escobar G, Ares S (1998) The hypothyroxinemia of prematurity. J Clin Endocrinol Metab 83: 713–715CrossRefGoogle Scholar
  94. 94.
    Ares S, Escobar-Morreale HF, Quero J et al (1997) Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab 82: 1704–1712PubMedCrossRefGoogle Scholar
  95. 95.
    Paul DA, Leef KH, Stefano JL, Bartoshesky L (1998) Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants. Pediatrics 101: 903–907PubMedCrossRefGoogle Scholar
  96. 96.
    Williams FL, Ogston SA, van Toor H et al (2005) Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 90: 5954–5963PubMedCrossRefGoogle Scholar
  97. 97.
    Lucas A, Rennie J, Baker BA, Morley R (1988) Low plasma triiodo- thyronine concentrations and outcome in preterm infants. Arch Dis Child 63: 1201–1206PubMedCrossRefGoogle Scholar
  98. 98.
    Osborn DA, Hunt RW (2007) Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database Syst Rev 1:CD005945Google Scholar
  99. 99.
    Reuss ML, Paneth N, Pinto-Martin JA et al (1996) The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 334: 821–827PubMedCrossRefGoogle Scholar
  100. 100.
    Biswas S, Buffery J, Enoch H et al (2003) Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial–thyroid hormone replacement in neonates. Pediatr Res 53: 48–56PubMedGoogle Scholar
  101. 101.
    Rooman RP, Du Caju MVL, De Beeck LO et al (1996) Low thyroxinaemia occurs in the majority of very preterm newboms. Eur J Ped 155: 211–215CrossRefGoogle Scholar
  102. 102.
    Calaciura F, Motta RM, Miscio G et al (2002) Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab 87: 3209–3214PubMedCrossRefGoogle Scholar
  103. 103.
    Leonardi D, Polizzotti N, Carta A et al (2008) Longitudinal study of thyroid function in children with mild hyperthyrotropinemia at neonatal screening for congenital hypothyroidism. J Clin Endocrinol Metab 93: 2679–85PubMedCrossRefGoogle Scholar
  104. 104.
    Tyfield LA, Abusrewil SS, Jones SR, Savage DC (1991) Persistent hyperthyrotropinaemia since the neonatal period in clinically euthyroid children. Eur J Pediatr 150: 308–309PubMedCrossRefGoogle Scholar
  105. 105.
    Surks MI, Ocampo E (1996) Subclinical thyroid disease. Am J Med 100: 217–223PubMedCrossRefGoogle Scholar
  106. 106.
    Gharib H, Tuttle RM, Baskin HJ et al (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 90: 581–587PubMedCrossRefGoogle Scholar
  107. 107.
    Polak M (1998) Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid 8: 1171–1177PubMedCrossRefGoogle Scholar
  108. 108.
    Zakarija M, McKenzie JM (1983) Pregnancy-associated changes in the thyroid-stimulating antibody of Graves’ disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 57: 1036–1040PubMedCrossRefGoogle Scholar
  109. 109.
    Polak M, Legac I, Vuillard E et al (2006) Congenital hyperthyroidism: the fetus as a patient. Horm Res 65: 235–242PubMedCrossRefGoogle Scholar
  110. 110.
    Spiegel AM (2000) G protein defects in signal transduction. Horm Res 53 (Supp13): 17–22PubMedCrossRefGoogle Scholar
  111. 111.
    Davis LE, Lucas MJ, Hankins GD et al (1989) Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160: 63–70PubMedGoogle Scholar
  112. 112.
    Zakarija M, McKenzie JM, Munro DS (1983) Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves’ disease. J Clin Invest 72: 1352–1356PubMedCrossRefGoogle Scholar
  113. 113.
    Luton D, Le Gac I, Vuillard E et al (2005) Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90: 6093–6098PubMedCrossRefGoogle Scholar
  114. 114.
    Hollingsworth DH, Mabry CC (1976) Congenital Graves’ disease: four familial cases with long-term follow-up and perspective. Am J Dis Child 130: 148–155PubMedGoogle Scholar
  115. 115.
    de Roux N, Polak M, Couet J et al (1996) A neomodulation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81: 2023–2026PubMedCrossRefGoogle Scholar
  116. 116.
    Luton D, Fried D, Sibony O et al (1997) Assessment of fetal thyroid function by colored Doppler echography. Fetal Diagn Ther 12: 24–27PubMedCrossRefGoogle Scholar
  117. 117.
    Daffos F, Capella-Pavlovsky M, Forestier F (1985) Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol 153: 655–660PubMedGoogle Scholar
  118. 118.
    Geffner DL, Azukizawa M, Hershman JM (1975) Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest 55: 224–229PubMedCrossRefGoogle Scholar
  119. 119.
    Pearce EN (2006) Diagnosis and management of thyrotoxicosis. BMJ 332: 1369–1373PubMedCrossRefGoogle Scholar
  120. 120.
    Transue D, Chan J, Kaplan M (1992) Management of neonatal Graves disease with iopanoic acid. J Pediatr 121: 472–474PubMedCrossRefGoogle Scholar
  121. 121.
    Lamberg BA, Ikonen E, Osterlund K et al (1984) Antithyroid treatment of maternal hyperthyroidism during lactation. Clin Endocrinol 21: 81–87CrossRefGoogle Scholar
  122. 122.
    Foulds N, Walpole I, Elmslie F, Mansour S (2005) Carbimazole embryopathy: an emerging phenotype. Am J Med Genet A 132: 130–135Google Scholar
  123. 123.
    DuPrez L, Parma J, Van Sande J et al (1994) Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyprthyroidism. Nat Genet 7: 396–401PubMedCrossRefGoogle Scholar
  124. 124.
    Shenker A, Weinstein LS, Moran A et al (1993) Severe endocrine and non-endocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 123: 509–518PubMedCrossRefGoogle Scholar
  125. 125.
    LinksKohn LD, Suzuki K, Hoffman WH et al (1997) Characterization of monoclonal thyroid-stimulating and thyrotropin bindinginhibiting autoantibodies from a Hashimoto’s patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab 82: 3998–4009CrossRefGoogle Scholar
  126. 126.
    Sunthornthepvarakui T, Gottschalk ME, Hayashi Y, Refetoff S (1995) Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 332: 155–160PubMedCrossRefGoogle Scholar
  127. 127.
    Refetoff S, Dumont J, Vassart G (2001) Thyroid disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New YorkGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Paolo Cavarzere
    • 1
  • Luciano Tatò
  1. 1.Department of Life and Reproduction SciencesUniversity of VeronaVeronaItaly

Personalised recommendations